Two firms fined for selling spurious cosmetic products

Thiruvananthapuram:  The Kerala Health Department’s campaign against fake and unsafe cosmetics—Operation Soundarya—has received clearance from the court. The initiative, led by the state’s Drugs Control Department, is to ensure the beauty and skincare products sold across the state meet basic safety and quality standards.

Recently, a Taliparamba  , Kannur-based company named Hazar Hazar Trading LLP was found guilty of selling fake beauty products. In another case, Gulfy Shop in Payyannur was also found guilty. The Judicial First Class Magistrate Court ordered each of the two accused to pay a fine of Rs. 10,000.

Operation Soundarya was launched in 2023 to curb the illegal sale of fake or dangerous beauty products. The department’s inspections have found a shocking range of products that are not only unauthorised but sometimes outright harmful.

In the first two phases of the operation, the investigation officers seized cosmetics worth over Rs. 7 lakh, many of which were either fake, lacked proper labels, or were manufactured in violation of safety laws.

Among the most alarming finds were lipsticks and face creams laced with mercury—in some cases, up to 12,000 times the permitted levels. Long-term use of such products can lead to serious health conditions including kidney failure, nerve damage, and other systemic illnesses.

In another instance, a perfume named “Karisma Perfume” was found to contain 95% methyl alcohol, a toxic and potentially fatal ingredient. Methyl alcohol is classified as a poison under Kerala’s laws, and its use in personal care products is strictly prohibited.

Following these investigations, Minister Veena George ordered intensified inspections across the state. The third phase saw inspections in 101 establishments, focusing on items like lipstick, face cream, baby powder, soap, and oil. Substandard products worth ₹1.5 lakh were seized, and 59 samples collected for further testing. Cases have been filed against 12 businesses for missing licenses or violating the Cosmetics Rules 2020

The Health Department has also called on the public to stay alert. The minister urged consumers to read product labels carefully, verify manufacturing and licensing information, and avoid buying products from suspicious or unverified outlets.

The department has set up a toll-free helpline (1800 425 3182) where people can file complaints or tip-offs about questionable beauty products or stores.

Related Posts

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Higher capacity utilisation, operating leverage and broad-based demand across CDMO, hospital generics and consumer healthcare are expected to support margins in FY27 Piramal Pharma expects to sustain mid-teen revenue growth…

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bhubaneswar: Researchers from the Sensors and Spectroscopy Research Group, School of Electrical and Computer Sciences (SECS), Indian Institute of Technology (IIT) Bhubaneswar, led by Dr. Sayan Dey, have made significant…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?